1990-2017年美国神经疾病负担:全球疾病负担研究
该研究系统分析全球疾病负担2017研究中美国各州14种主要神经疾病的发病率、患病率、死亡率和伤残调整生命年(DALYs)。结果显示卒中、阿尔茨海默病及其他痴呆、偏头痛的DALYs最高,多数神经疾病负担因人口老龄化而增加,但创伤性脑损伤、脊髓损伤、脑膜炎和脑炎的部分指标下降。各州年龄标化率差异可达7.5倍。
要点
- 卒中、痴呆和偏头痛是美国DALYs最高的三种神经疾病。
- 1990-2017年多数神经疾病负担绝对数增加,主要与人口老龄化相关。
- 各州年龄标化率差异显著,从紧张型头痛的1.2倍到破伤风的7.5倍。
核心结论
- 美国非传染性神经疾病负担巨大且不断增加,各州负担和趋势差异可达5倍。
研究设计与样本
- 系统分析全球疾病负担2017研究,纳入美国48个相邻州、阿拉斯加和夏威夷,分析14种主要神经疾病。
- 计算按年龄和性别的绝对数及年龄标化率(含95%不确定性区间)。
主要发现
- DALYs绝对数最高的三种疾病:卒中3.58百万(95%UI 3.25-3.92),阿尔茨海默病及其他痴呆2.55百万(95%UI 2.43-2.68),偏头痛2.40百万(95%UI 1.53-3.44)。
- 1990-2017年多数神经疾病绝对负担增加,主要因人口老龄化。
- 部分指标下降:创伤性脑损伤发病率-29.1%(95%UI -32.4%至-25.8%),脊髓损伤患病率-38.5%(95%UI -43.1%至-34.0%),脑膜炎患病率-44.8%(95%UI -47.3%至-42.3%)、死亡-64.4%(95%UI -67.7%至-50.3%)、DALYs -66.9%(95%UI -70.1%至-55.9%),脑炎DALYs -25.8%(95%UI -30.7%至-5.8%)。
- 各州年龄标化率差异从紧张型头痛的1.2倍到破伤风的7.5倍。
- 东南部州和阿肯色州卒中负担较高;北部州多发性硬化负担较高;东部州帕金森病、特发性癫痫、偏头痛和紧张型头痛及脑膜炎、脑炎、破伤风率较高。
临床怎么用
- 可为国家和州层面医疗规划及资源分配提供依据,以预防和减少神经疾病负担。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Accurate and up-to-date estimates on incidence, prevalence, mortality, and disability-adjusted life-years (burden) of neurological disorders are the backbone of evidence-based health care planning and resource allocation for these disorders. It appears that no such estimates have been reported at the state level for the US. OBJECTIVE: To present burden estimates of major neurological disorders in the US states by age and sex from 1990 to 2017. DESIGN, SETTING, AND PARTICIPANTS: This is a systematic analysis of the Global Burden of Disease (GBD) 2017 study. Data on incidence, prevalence, mortality, and disability-adjusted life-years (DALYs) of major neurological disorders were derived from the GBD 2017 study of the 48 contiguous US states, Alaska, and Hawaii. Fourteen major neurological disorders were analyzed: stroke, Alzheimer disease and other dementias, Parkinson disease, epilepsy, multiple sclerosis, motor neuron disease, migraine, tension-type headache, traumatic brain injury, spinal cord injuries, brain and other nervous system cancers, meningitis, encephalitis, and tetanus. EXPOSURES: Any of the 14 listed neurological diseases. MAIN OUTCOME AND MEASURE: Absolute numbers in detail by age and sex and age-standardized rates (with 95% uncertainty intervals) were calculated. RESULTS: The 3 most burdensome neurological disorders in the US in terms of absolute number of DALYs were stroke (3.58 [95% uncertainty interval [UI], 3.25-3.92] million DALYs), Alzheimer disease and other dementias (2.55 [95% UI, 2.43-2.68] million DALYs), and migraine (2.40 [95% UI, 1.53-3.44] million DALYs). The burden of almost all neurological disorders (in terms of absolute number of incident, prevalent, and fatal cases, as well as DALYs) increased from 1990 to 2017, largely because of the aging of the population. Exceptions for this trend included traumatic brain injury incidence (-29.1% [95% UI, -32.4% to -25.8%]); spinal cord injury prevalence (-38.5% [95% UI, -43.1% to -34.0%]); meningitis prevalence (-44.8% [95% UI, -47.3% to -42.3%]), deaths (-64.4% [95% UI, -67.7% to -50.3%]), and DALYs (-66.9% [95% UI, -70.1% to -55.9%]); and encephalitis DALYs (-25.8% [95% UI, -30.7% to -5.8%]). The different metrics of age-standardized rates varied between the US states from a 1.2-fold difference for tension-type headache to 7.5-fold for tetanus; southeastern states and Arkansas had a relatively higher burden for stroke, while northern states had a relatively higher burden of multiple sclerosis and eastern states had higher rates of Parkinson disease, idiopathic epilepsy, migraine and tension-type headache, and meningitis, encephalitis, and tetanus. CONCLUSIONS AND RELEVANCE: There is a large and increasing burden of noncommunicable neurological disorders in the US, with up to a 5-fold variation in the burden of and trends in particular neurological disorders across the US states. The information reported in this article can be used by health care professionals and policy makers at the national and state levels to advance their health care planning and resource allocation to prevent and reduce the burden of neurological disorders.
引用
- Feigin VL, Vos T, Alahdab F, et al. Burden of Neurological Disorders Across the US From 1990-2017: A Global Burden of Disease Study. JAMA Neurol. 2021. PMID: 33136137. doi:10.1001/jamaneurol.2020.4152
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。